N-(4-(2-(Cycloheptylamino)-2-oxoethyl)thiazol-2-yl)furan-2-carboxamide

Catalog No. :
ACYQUP436
CAS No. :
857040-20-1
Molecular Formula :
C17H21N3O3S
Molecular Weight :
347.44

IUPAC Name:N-(4-(2-(cycloheptylamino)-2-oxoethyl)thiazol-2-yl)furan-2-carboxamide

N-(4-(2-(Cycloheptylamino)-2-oxoethyl)thiazol-2-yl)furan-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$125.00Login to see priceInquiryInquiry
25mg98%$400.00Login to see priceInquiryInquiry
50mg98%$754.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-(2-(Cycloheptylamino)-2-oxoethyl)thiazol-2-yl)furan-2-carboxamide
IUPAC NameN-(4-(2-(cycloheptylamino)-2-oxoethyl)thiazol-2-yl)furan-2-carboxamide
Molecular FormulaC17H21N3O3S
Molecular Weight347.44
SMILESO=C(NC1CCCCCC1)CC2=CSC(NC(C3=CC=CO3)=O)=N2
InChI KeyKXTKUOQGRMFVKE-UHFFFAOYSA-N
SynonymN-cycloheptyl-2-[(2-furanylcarbonyl)amino]-4-Thiazoleacetamide | N-(4-(2-(cycloheptylamino)-2-oxoethyl)thiazol-2-yl)furan-2-carboxamide
CAS No.857040-20-1
PubChem CID4792837

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACYQUP436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQUP436 route product structure diagram
    ACYQUP436857040-20-1
Inquiry

2. ACYQUP436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCLNO712 route compound structure diagram
    ACCLNO7125452-35-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQUP436 route product structure diagram
    ACYQUP436857040-20-1
Inquiry

Comments (0)